封面
市场调查报告书
商品编码
1424380

小容量注射剂的全球市场:按型态、按剂量类型、按包装类型、按适应症类型、按最终用户、按地区

Global Small Volume Parenteral Market, By Form, By Dose Type, By Packaging Type, By Indication Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2030 年,小容量注射剂的全球市场规模将从 2023 年的 1,796.2 亿美元增至 2,985.7 亿美元,预测期内年复合成长率(CAGR)为 7.5%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 1796.2亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率: 7.50% 2030/2031价值预测 2985.7亿美元
图 1. 2023 年小容量注射製剂的全球市场占有率(按地区划分)
全球小容量注射剂市场-IMG1

小容量注射药物市场由注射剂量较小(通常小于 100 毫升)的注射药物和製剂组成。小剂量注射製剂广泛应用于治疗糖尿病、癌症、感染疾病、郁血性心臟衰竭等。静脉注射、肌肉内、皮下和皮内给药等途径可以将药物直接输送到血液中。由于全球慢性和急性疾病的盛行率不断增加,小容量注射剂市场正在稳步成长。此外,日益增长的老龄化人口容易受到多种健康状况的影响,这推动了对易于小剂量给药的药物的需求。然而,注射剂生产的严格监管以及市场开拓的高成本可能会在一定程度上阻碍市场的扩张。

市场动态:

全球小容量注射药物市场主要是由糖尿病、心血管疾病、癌症和呼吸系统疾病等慢性病盛行率上升所推动的。根据世界卫生组织(WHO)估计,2020年,慢性病将占全球死亡人数的70%以上。此外,不断增长的老年人口容易受到多种健康问题的影响,对小剂量胃肠外製剂的需求也随之增加,以应对复杂的病理。此外,精确剂量、即时给药和绕过胃肠道吸收等优点正在推动小容量肠胃外製剂的采用。然而,与注射药物开发相关的高成本和注射药物製造的严格法律规范继续限制市场成长。同时,新型药物输送系统的进步预计将为相关人员提供有利可图的机会。

本研究的主要特点

  • 本报告对全球小剂量注射药物市场进行了详细分析,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球小容量注射药物市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 小容量注射剂全球市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球小容量注射药物市场的各种策略矩阵,将促进相关人员的决策。

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场概况

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第 3 章 关键产业见解

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
  • 影响分析
  • PEST分析
  • 波特的分析
  • 技术进步
  • 合併、收购和合作场景
  • 最近的产品核准/发布
  • 公司市场占有率分析

第 4 章 小容量注射药物市场,依型态,2018-2030

  • 液体
  • 烘干

第五章小容量注射药物市场,依剂量类型,2018-2030

  • 单一剂量
  • 多次给药

第六章小容量注射药物市场,依包装类型,2018-2030

  • 安瓿
  • 管瓶
  • 预填充式注射器
  • 墨水匣
  • 瓶子
  • 其他的

第七章小容量注射剂市场,依适应症类型,2018-2030

  • 疼痛管理
  • 癌症治疗
  • 营养不良
  • 胃肠道疾病/腹泻
  • 其他的

第 8 章 小容量注射药物市场,依最终使用者划分,2018-2030 年

  • 医院
  • 诊所
  • 门诊手术中心年
  • 其他的

第九章小容量注射剂市场,按地区,2018-2030

  • 按地区
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东和非洲
  • GCC
  • 以色列
  • 其他中东地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷

第十章公司简介-小容量注射药物市场

  • Fresenius Kabi AG
    • 公司简介
    • 产品/服务组合
    • 财务绩效
    • 最新动态/最新讯息
    • 策略概览
  • Baxter
  • Sichuan Kelun
  • BML Parenteral Drugs
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • WuXi AppTec
  • Akums Drugs & Pharmaceuticals Ltd.
  • Orion Corporation
  • Rusoma Laboratories Private Limited
  • Higgs Healthcare
  • Syntegon Technology GmbH

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6522

Global small volume parenteral market size is expected to reach US$ 298.57 Bn by 2030, from US$ 179.62 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 179.62 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.50% 2030/2031 Value Projection: US$ 298.57 Bn
Figure 1. Global Small Volume Parenteral Market Share (%), By Region, 2023
Global Small Volume Parenteral Market - IMG1

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and congestive heart failures. They aid in delivering medications directly into the bloodstream through routes such as intravenous, intramuscular, subcutaneous, and intradermal delivery. The small volume parenteral formulations market has been witnessing steady growth driven by the growing prevalence of chronic and acute diseases worldwide. Moreover, the rising geriatric population prone to multiple health conditions has boosted the demand for easily administrable drugs in mini doses. However, stringent regulations for manufacturing parenteral drugs and high costs that are associated with drug development may impede the market expansion to some extent.

Market Dynamics:

Global small volume parenteral market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases. As per the estimates of World Health Organization (WHO), chronic diseases accounted for over 70% of all deaths worldwide in 2020. Growing geriatric population base which is also susceptible to multiple health issues, has intensified the demand for small volume parenteral formulations to manage complex conditions. Furthermore, advantages such as precise dosing, immediate delivery of medication, and bypassing gastrointestinal absorption have augmented the adoption of small volume parenteral. However, high costs associated with parenteral drug development and stringent regulatory framework for manufacturing injectable drugs continues to restrict the market growth. On the other hand, ongoing advancements in novel drug delivery systems are expected to unleash lucrative opportunities for stakeholders.

Key features of the study:

  • This report provides in-depth analysis of the global small volume parenteral market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global small volume parenteral market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical, Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global small volume parenteral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small volume parenteral market

Detailed Segmentation:

  • Global Small Volume Parenteral Market, By Form
    • Liquid
    • Dry
  • Global Small Volume Parenteral Market, By Dosage Type
    • Single-dose
    • Multiple-dose
  • Global Small Volume Parenteral Market, By Packaging Type
    • Ampoules
    • Vials
    • Pre-filled Syringes
    • Cartridges
    • Bottles
    • Others
  • Global Small Volume Parenteral Market, By Indication Type
    • Pain Management
    • Cancer Care
    • Malnourishment
    • Gastrointestinal disorder/Diarrhea
    • Diabetes
    • Others
  • Global Small Volume Parenteral Market, By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Small Volume Parenteral Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Small Volume Parenteral Market:
    • Fresenius Kabi AG
    • Baxter
    • Sichuan Kelun
    • BML Parenteral Drugs
    • ICU Medical, Inc.
    • Pfizer Inc.
    • Becton Dickinson and Company
    • Braun Melsungen AG
    • WuXi AppTec
    • Akums Drugs & Pharmaceuticals Ltd.
    • Orion Corporation
    • Rusoma Laboratories Private Limited
    • Higgs Healthcare
    • Syntegon Technology GmbH

Table of Content

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Top 3 Market Findings
    • Top 3 Market Opportunity

3. Key Industry Insights

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals/Launches
  • Company Market Share Analysis

4. Small Volume Parenteral Market, By Form, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Liquid, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Dry, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

5. Small Volume Parenteral Market, By Dose Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Single-dose, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Multiple-dose, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

6. Small Volume Parenteral Market, By Packaging Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Ampoules, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Vials, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Pre-filled Syringes, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Cartridges, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Bottles, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

7. Small Volume Parenteral Market, By Indication Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Share Analysis, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Cancer Care, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Malnourishment, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Gastrointestinal Disorder/diarrhea, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Diabetes, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

8. Small Volume Parenteral Market, By End User, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Hospitals, 2018 - 2030( US$ Billion)
  • Clinics, 2018 - 2030( US$ Billion)
  • Ambulatory Surgical Centers, 2018 - 2030( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)

9. Small Volume Parenteral Market, By Region, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • North America
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest Of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • GCC
  • Israel
  • Rest Of Middle East
  • Latin America
    • Introduction
    • Market Size and Forecast, By Form, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Dose Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Packaging Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Indication Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End User, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • Brazil
  • Mexico
  • Argentina

10. Company Profiles - Small Volume Parenteral Market

  • Fresenius Kabi AG*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
  • Strategic Overview
  • Baxter
  • Sichuan Kelun
  • BML Parenteral Drugs
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • WuXi AppTec
  • Akums Drugs & Pharmaceuticals Ltd.
  • Orion Corporation
  • Rusoma Laboratories Private Limited
  • Higgs Healthcare
  • Syntegon Technology GmbH

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact